Absolutely. However, with GLP-1 agonists there are two main conditions which we're very concerned about. They're both rare, but I always like to mention them. The first is any personal or family history of medullary thyroid cancer and second is any prior history of acute pancreatitis. Those would be reasons why we would not do GLP-1 agonists, but otherwise, in most patients, they're perfectly fine.